Related Experiment Video
Updated: May 21, 2026

Assessment of Myofilament Ca2+ Sensitivity Underlying Cardiac Excitation-contraction Coupling
Published on: August 1, 2016
Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome
Evangelia G Kranias1, Roger J Hajjar
1Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0575, USA. Litsa.Kranias@uc.edu
Insights
Heart failure impairs cardiac contractility by affecting calcium handling. New research reveals complex regulation of the SERCA2 pump by phospholamban and other proteins, offering novel therapeutic targets.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Heart disease is a leading cause of death, with heart failure characterized by impaired contractile function.
- Current therapies address symptoms, not underlying subcellular mechanisms of heart failure.
- Impaired calcium sequestration into the sarcoplasmic reticulum (SR) is a hallmark of failing hearts.
Purpose of the Study:
- To review the regulatory mechanisms of cardiac contractility involving the SERCA/PLN complex.
- To explore new therapeutic strategies targeting this complex for heart failure treatment.
Main Methods:
- Literature review of studies on cardiac calcium handling and SERCA2 regulation.
- Analysis of the roles of phospholamban (PLN) and newly identified regulatory proteins.
- Discussion of potential small molecule and gene transfer therapies.
Main Results:
- The SERCA2 pump's activity is regulated by phospholamban (PLN), with phosphorylation relieving inhibition.
- New regulators of SERCA activity include SUMO, S100, and histidine-rich Ca-binding protein.
- PLN activity is further modulated by inhibitor-1 of protein phosphatase 1 and small heat shock protein 20.
Conclusions:
- Cardiac contractility is regulated by a multimeric SERCA/PLN ensemble.
- Understanding these complex regulatory mechanisms opens avenues for novel heart failure therapeutics.
- Targeting the SERCA/PLN complex with small molecules or gene transfer shows therapeutic potential.
Abstract:
Heart disease remains the leading cause of death and disability in the Western world. Current therapies aim at treating the symptoms rather than the subcellular mechanisms, underlying the etiology and pathological remodeling in heart failure. A universal characteristic, contributing to the decreased contractile performance in human and experimental failing hearts, is impaired calcium sequestration into the sarcoplasmic reticulum (SR). SR calcium uptake is mediated by a Ca(2+)-ATPase (SERCA2), whose activity is reversibly regulated by phospholamban (PLN). Dephosphorylated PLN is an inhibitor of SERCA and phosphorylation of PLN relieves this inhibition. However, the initial simple view of a PLN/SERCA regulatory complex has been modified by our recent identification of SUMO, S100 and the histidine-rich Ca-binding protein as regulators of SERCA activity. In addition, PLN activity is regulated by 2 phosphoproteins, the inhibitor-1 of protein phosphatase 1 and the small heat shock protein 20, which affect the overall SERCA-mediated Ca-transport. This review will highlight the regulatory mechanisms of cardiac contractility by the multimeric SERCA/PLN-ensemble and the potential for new therapeutic avenues targeting this complex by using small molecules and gene transfer methods.
More Related Videos
06:22Contractility Measurements on Isolated Papillary Muscles for the Investigation of Cardiac Inotropy in Mice
Published on: September 17, 2015
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
Related Concept Videos
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Pathophysiology of Cardiac Performance
Smooth Muscle Contraction
The onset of contraction is triggered by an increase in calcium ions within the sarcoplasm, similar to the process in striated muscle. However, smooth muscles have a relatively smaller reservoir of the sarcoplasmic...
Heart Failure II: Pathophysiology
cAMP-dependent Protein Kinase Pathways